Several studies using pre-clinical models have demonstrated the involvement of COX-2/Prostaglandin E2 (PGE2) pathway in various steps during breast cancer progression, including primary tumor growth [9], metastasis [10, 11], angiogenesis [12], and immune evasion [13]. Here, PTGS2 is linked to breast carcinoma.